Real-time detection of cancer cells during surgical removal of a tumor is important.
Currently when tissue is removed at the time of surgery, the removed tissue goes to pathology
when the margins (edges of the tissue) are examined to see if cancer cells are present. This
may take a few to several days. Patients tissue with positive (cancer cells present) margins
may require additional therapies including surgery. The purpose of this study is to determine
a safe dose of a new imaging agent (LUM015), like a fluorescent contrast agent or dye, that
will show in the tumor area during surgery and may help facilitate visualization of tumor for
its removal.